Gene therapy biotech uniQure is prioritizing its drug pipeline to develop treatments for Huntington’s disease, hemophilia B, and its partnered…
Articles by Charles Moore
A multi-institutional study led by a team of biomedical researchers in the lab of Hui-Chen Lu at Indiana University at…
Cambridge, England-based light therapy specialist Lumie will supply 24 of its most powerful light boxes, called …
Texas Tech University Health Sciences Center (TTUHSC) researchers have identified a molecule — mitochondrial division inhibitor 1 (Mdivi1) — believed…
Neurodegenerative diseases (ND) represent a major and growing healthcare problem, especially in developed nations with aging populations. These disorders affect…
In 2013, the U.S. Food and Drug administration (FDA) selected Huntington’s disease (HD) and Parkinson’s disease (PD) as the focus…
Huntington’s disease is among a select group of disorders for which eligible patients can be prescribed medical marijuana in New York State. A bill…
Mitochondria, the true energy power plants of cellular activity, play a vital role in energy production and in several other…
As part of its ongoing effort to improve mitochondrial disease patient care, MitoAction — a nonprofit organization dedicated…
A new international study by scientists at the University of Granada (UGR) in Spain, the University of Wisconsin-Madison, Columbia University…